Laser-Assisted Delivery of Topical Rapamycin: mTOR Inhibition for Birt–Hogg–Dube Syndrome
Gespeichert in:
| Veröffentlicht in: | Dermatologic surgery 2019-12, Vol.45 (12), p.1713-1715 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1715 |
|---|---|
| container_issue | 12 |
| container_start_page | 1713 |
| container_title | Dermatologic surgery |
| container_volume | 45 |
| creator | Kim, David Wysong, Ashley Teng, Joyce M Rahman, Zakia |
| description | |
| doi_str_mv | 10.1097/DSS.0000000000001778 |
| format | Article |
| fullrecord | <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1097_DSS_0000000000001778</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>30640787</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3238-1b2061c03255c80be08d1c71dd627dac0aa2e2d6a23d8c6e4fc1835190f208363</originalsourceid><addsrcrecordid>eNp9kM1OAjEUhRujEUXfwJi-wOBtOzMt7hBUSEhIAJdm0mk7UJ0f0g6S2fkOvqFP4hjUGBfezbmL75zFh9AFgR6BPr8aLRY9-HWEc3GATkhEwyDkNDpsf-BxABGhHXTq_VPL0D6DY9RhEIfABT9Bj1PpjQsG3ltfG41HJrcvxjW4yvCy2lglczyXG1k0ypbXuFjO5nhSrm1qa1uVOKscvrGufn99G1erVRujbWrwoim1qwpzho4ymXtz_pVd9HB3uxyOg-nsfjIcTAPFKBMBSSnERAGjUaQEpAaEJooTrWPKtVQgJTVUx5IyLVRswkwRwSLSh4yCYDHronC_q1zlvTNZsnG2kK5JCCSftpLWVvLXVlu73Nc227Qw-qf0racFxB7YVXltnH_OtzvjkrWReb3-f_sDnXt30g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Laser-Assisted Delivery of Topical Rapamycin: mTOR Inhibition for Birt–Hogg–Dube Syndrome</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>Kim, David ; Wysong, Ashley ; Teng, Joyce M ; Rahman, Zakia</creator><creatorcontrib>Kim, David ; Wysong, Ashley ; Teng, Joyce M ; Rahman, Zakia</creatorcontrib><identifier>ISSN: 1076-0512</identifier><identifier>EISSN: 1524-4725</identifier><identifier>DOI: 10.1097/DSS.0000000000001778</identifier><identifier>PMID: 30640787</identifier><language>eng</language><publisher>United States: by the American Society for Dermatologic Surgery, Inc. Published by Wolters Kluwer Health, Inc. All rights reserved</publisher><subject>Administration, Cutaneous ; Aged ; Biopsy ; Birt-Hogg-Dube Syndrome - diagnosis ; Birt-Hogg-Dube Syndrome - drug therapy ; Birt-Hogg-Dube Syndrome - genetics ; Combined Modality Therapy - instrumentation ; Combined Modality Therapy - methods ; Humans ; Lasers ; Low-Level Light Therapy - instrumentation ; Low-Level Light Therapy - methods ; Male ; Ointments ; Proto-Oncogene Proteins - genetics ; Proto-Oncogene Proteins - metabolism ; Signal Transduction - drug effects ; Signal Transduction - genetics ; Sirolimus - administration & dosage ; Skin - drug effects ; Skin - pathology ; Skin - radiation effects ; TOR Serine-Threonine Kinases - antagonists & inhibitors ; TOR Serine-Threonine Kinases - metabolism ; Treatment Outcome ; Tumor Suppressor Proteins - genetics ; Tumor Suppressor Proteins - metabolism</subject><ispartof>Dermatologic surgery, 2019-12, Vol.45 (12), p.1713-1715</ispartof><rights>2019 by the American Society for Dermatologic Surgery, Inc. Published by Wolters Kluwer Health, Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3238-1b2061c03255c80be08d1c71dd627dac0aa2e2d6a23d8c6e4fc1835190f208363</citedby><cites>FETCH-LOGICAL-c3238-1b2061c03255c80be08d1c71dd627dac0aa2e2d6a23d8c6e4fc1835190f208363</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30640787$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kim, David</creatorcontrib><creatorcontrib>Wysong, Ashley</creatorcontrib><creatorcontrib>Teng, Joyce M</creatorcontrib><creatorcontrib>Rahman, Zakia</creatorcontrib><title>Laser-Assisted Delivery of Topical Rapamycin: mTOR Inhibition for Birt–Hogg–Dube Syndrome</title><title>Dermatologic surgery</title><addtitle>Dermatol Surg</addtitle><subject>Administration, Cutaneous</subject><subject>Aged</subject><subject>Biopsy</subject><subject>Birt-Hogg-Dube Syndrome - diagnosis</subject><subject>Birt-Hogg-Dube Syndrome - drug therapy</subject><subject>Birt-Hogg-Dube Syndrome - genetics</subject><subject>Combined Modality Therapy - instrumentation</subject><subject>Combined Modality Therapy - methods</subject><subject>Humans</subject><subject>Lasers</subject><subject>Low-Level Light Therapy - instrumentation</subject><subject>Low-Level Light Therapy - methods</subject><subject>Male</subject><subject>Ointments</subject><subject>Proto-Oncogene Proteins - genetics</subject><subject>Proto-Oncogene Proteins - metabolism</subject><subject>Signal Transduction - drug effects</subject><subject>Signal Transduction - genetics</subject><subject>Sirolimus - administration & dosage</subject><subject>Skin - drug effects</subject><subject>Skin - pathology</subject><subject>Skin - radiation effects</subject><subject>TOR Serine-Threonine Kinases - antagonists & inhibitors</subject><subject>TOR Serine-Threonine Kinases - metabolism</subject><subject>Treatment Outcome</subject><subject>Tumor Suppressor Proteins - genetics</subject><subject>Tumor Suppressor Proteins - metabolism</subject><issn>1076-0512</issn><issn>1524-4725</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kM1OAjEUhRujEUXfwJi-wOBtOzMt7hBUSEhIAJdm0mk7UJ0f0g6S2fkOvqFP4hjUGBfezbmL75zFh9AFgR6BPr8aLRY9-HWEc3GATkhEwyDkNDpsf-BxABGhHXTq_VPL0D6DY9RhEIfABT9Bj1PpjQsG3ltfG41HJrcvxjW4yvCy2lglczyXG1k0ypbXuFjO5nhSrm1qa1uVOKscvrGufn99G1erVRujbWrwoim1qwpzho4ymXtz_pVd9HB3uxyOg-nsfjIcTAPFKBMBSSnERAGjUaQEpAaEJooTrWPKtVQgJTVUx5IyLVRswkwRwSLSh4yCYDHronC_q1zlvTNZsnG2kK5JCCSftpLWVvLXVlu73Nc227Qw-qf0racFxB7YVXltnH_OtzvjkrWReb3-f_sDnXt30g</recordid><startdate>201912</startdate><enddate>201912</enddate><creator>Kim, David</creator><creator>Wysong, Ashley</creator><creator>Teng, Joyce M</creator><creator>Rahman, Zakia</creator><general>by the American Society for Dermatologic Surgery, Inc. Published by Wolters Kluwer Health, Inc. All rights reserved</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>201912</creationdate><title>Laser-Assisted Delivery of Topical Rapamycin: mTOR Inhibition for Birt–Hogg–Dube Syndrome</title><author>Kim, David ; Wysong, Ashley ; Teng, Joyce M ; Rahman, Zakia</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3238-1b2061c03255c80be08d1c71dd627dac0aa2e2d6a23d8c6e4fc1835190f208363</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Administration, Cutaneous</topic><topic>Aged</topic><topic>Biopsy</topic><topic>Birt-Hogg-Dube Syndrome - diagnosis</topic><topic>Birt-Hogg-Dube Syndrome - drug therapy</topic><topic>Birt-Hogg-Dube Syndrome - genetics</topic><topic>Combined Modality Therapy - instrumentation</topic><topic>Combined Modality Therapy - methods</topic><topic>Humans</topic><topic>Lasers</topic><topic>Low-Level Light Therapy - instrumentation</topic><topic>Low-Level Light Therapy - methods</topic><topic>Male</topic><topic>Ointments</topic><topic>Proto-Oncogene Proteins - genetics</topic><topic>Proto-Oncogene Proteins - metabolism</topic><topic>Signal Transduction - drug effects</topic><topic>Signal Transduction - genetics</topic><topic>Sirolimus - administration & dosage</topic><topic>Skin - drug effects</topic><topic>Skin - pathology</topic><topic>Skin - radiation effects</topic><topic>TOR Serine-Threonine Kinases - antagonists & inhibitors</topic><topic>TOR Serine-Threonine Kinases - metabolism</topic><topic>Treatment Outcome</topic><topic>Tumor Suppressor Proteins - genetics</topic><topic>Tumor Suppressor Proteins - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kim, David</creatorcontrib><creatorcontrib>Wysong, Ashley</creatorcontrib><creatorcontrib>Teng, Joyce M</creatorcontrib><creatorcontrib>Rahman, Zakia</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Dermatologic surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kim, David</au><au>Wysong, Ashley</au><au>Teng, Joyce M</au><au>Rahman, Zakia</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Laser-Assisted Delivery of Topical Rapamycin: mTOR Inhibition for Birt–Hogg–Dube Syndrome</atitle><jtitle>Dermatologic surgery</jtitle><addtitle>Dermatol Surg</addtitle><date>2019-12</date><risdate>2019</risdate><volume>45</volume><issue>12</issue><spage>1713</spage><epage>1715</epage><pages>1713-1715</pages><issn>1076-0512</issn><eissn>1524-4725</eissn><cop>United States</cop><pub>by the American Society for Dermatologic Surgery, Inc. Published by Wolters Kluwer Health, Inc. All rights reserved</pub><pmid>30640787</pmid><doi>10.1097/DSS.0000000000001778</doi><tpages>3</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1076-0512 |
| ispartof | Dermatologic surgery, 2019-12, Vol.45 (12), p.1713-1715 |
| issn | 1076-0512 1524-4725 |
| language | eng |
| recordid | cdi_crossref_primary_10_1097_DSS_0000000000001778 |
| source | MEDLINE; Journals@Ovid Complete |
| subjects | Administration, Cutaneous Aged Biopsy Birt-Hogg-Dube Syndrome - diagnosis Birt-Hogg-Dube Syndrome - drug therapy Birt-Hogg-Dube Syndrome - genetics Combined Modality Therapy - instrumentation Combined Modality Therapy - methods Humans Lasers Low-Level Light Therapy - instrumentation Low-Level Light Therapy - methods Male Ointments Proto-Oncogene Proteins - genetics Proto-Oncogene Proteins - metabolism Signal Transduction - drug effects Signal Transduction - genetics Sirolimus - administration & dosage Skin - drug effects Skin - pathology Skin - radiation effects TOR Serine-Threonine Kinases - antagonists & inhibitors TOR Serine-Threonine Kinases - metabolism Treatment Outcome Tumor Suppressor Proteins - genetics Tumor Suppressor Proteins - metabolism |
| title | Laser-Assisted Delivery of Topical Rapamycin: mTOR Inhibition for Birt–Hogg–Dube Syndrome |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T00%3A00%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Laser-Assisted%20Delivery%20of%20Topical%20Rapamycin:%20mTOR%20Inhibition%20for%20Birt%E2%80%93Hogg%E2%80%93Dube%20Syndrome&rft.jtitle=Dermatologic%20surgery&rft.au=Kim,%20David&rft.date=2019-12&rft.volume=45&rft.issue=12&rft.spage=1713&rft.epage=1715&rft.pages=1713-1715&rft.issn=1076-0512&rft.eissn=1524-4725&rft_id=info:doi/10.1097/DSS.0000000000001778&rft_dat=%3Cpubmed_cross%3E30640787%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/30640787&rfr_iscdi=true |